Abstract:Background Airway hyperresponsiveness (AHR) is one of the most important characteristics of asthma. This study investigated the parameters, by which assess the airway responsiveness under tidal ventilation.Methods Female BALB/c mice were sensitized and challenged with ovalbumin (OVA) (group A), and part of them were treated with budesonide aerosol ( group B). All the mice were anaesthetized and mechanically ventilated. The values of tidal volume (V-1), airway pressure P,), airway flow ( F), expiratory lung resistance (R-L) and dynamic compliance of the thorax and lung (CT-L) were recorded by the AniRes2003 animal lung function system. In addition, the expiratory volume in the first 0.1 second after the start of expiration (EV0.1) was obtained according to the flow-volume (F-V) curve. The maximal or minimal values of EV0.1, R-L and CT-L were documented after each dose of methacholine (MCH) and compared with values from negative control group (group C).Results (1) When the dose of MCH reached 100 ng/g or 200 ng/g, the decrease of V, in group A was much more significant than group C (P = 0.001, < 0.001 respectively), but not so between groups B and group C (P = 0.974, 0.362 respectively. (2) With the dose of 25, 50, 100 or 200 ng/g MCH, the decrease in percentage of EV0.1 in group A was much higher than group C ( P = 0.012, 0.025, 0.001, 0. 003 respectively), while that in group B showed no significant difference as compared with group C (P = 0. 507, 0. 896, 0.972, 0.785). (3) RL and CT-L: with the dose of 200 ng/g MCH, there was a statistically significant increase of RL in group A compared to group B or group C (P < 0.001, < 0. 001 respectively), but no significant difference between groups B and C (P = 0.266). With doses of 100 ng/g and 200 ng/g MCH, there was a statistically significant decrease of CT-L in group A compared to group B (P = 0.001 0.001) and group C (P < 0. 001, < 0.001 respectively), but no significant difference between groups B and C ( P = 0.775, 0.310). (4) Histopathology: there were eosinophilic predominant peribronchial and perivascular inflammatory influx in murine lungs after OVA sensitizing and challenging, which could be counteracted by inhalation of budesonide in group B.Conclusions The decline in EV0.1 in response to MCH challenge correlated with simultaneous changes in V,, R, and CT-L, but more sensitively than all the other parameters. The decline in EV0.1 and inflammation in murine lung could be significantly alleviated by inhalation of nebulized budesonide solution, which indicated that EV0.1 to MCH is a valid measure of AHR in mice.

Nebulized MIDD0301 Reduces Airway Hyperresponsiveness in Moderate and Severe Murine Asthma Models

Effects of Chuankezhi Injection on Airway Inflammation in Mouse Model of Asthma and Isolated Guinea-Pig Airway Smooth Muscle

Development of Inhaled GABAA Receptor Modulators to Improve Airway Function in Bronchoconstrictive Disorders

Investigation of the Measurement of Murine Airway Hyperresponsiveness and the Therapeutic Effects of Budesonide on Ovalbumin Sensitized and Challenged Mice

M3 muscarinic receptor antagonist bencycloquidium bromide attenuates allergic airway inflammation, hyperresponsiveness and remodeling in mice

Imidazobenzodiazepine PI320 Relaxes Mouse Peripheral Airways by Inhibiting Calcium Mobilization

Effects of Phosphodiesterase 4 Inhibitor on Cough Response in Guinea Pigs Sensitized and Challenged with Ovalbumin

In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients

Effects of Ozone Repeated Short Exposures on the Airway/lung Inflammation, Airway Hyperresponsiveness and Mucus Production in a Mouse Model of Ovalbumin-Induced Asthma.

The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma

MG53 alleviates airway inflammatory responses by regulating nuclear factor-κB pathway in asthmatic mice

Acetamide-45 Inhibited Hyperresponsiveness and Airway Inflammation in Mice Partly Depending on Phosphodiesterase Activity Suppression

Effects of the Inhalation of the M3 Receptor Antagonist Bencycloquidium Bromide in A Mouse Cigarette Smoke-Induced Airway Inflammation Model.

Immunomodulatory innate defence regulator (IDR) peptide alleviates airway inflammation and hyper-responsiveness

Mycophenolate Mofetil, an Inhibitor of Inosine Monophosphate Dehydrogenase, and Tofacitinib, a Janus Kinase Inhibitor, Attenuate Airway Inflammation and Hyperresponsiveness in a Mouse Model of Allergic Asthma

Antagonism of m3 Alleviates Type 2 Inflammation in Allergic Rhinitis Mice.

Bronchodilatory effect of higenamine as antiallergic asthma treatment

New promising agents against COPD and asthma among the amides of 1-oxo-3-phenyl-isochroman-6-carboxylic acid

Dynamic Changes in Airway Hyperresponsiveness As a Result of Allergen and Therapeutic Effects of Budesonide in Rats

Effects of 101BHG-D01, a Novel M Receptor Antagonism, on Allergic Rhinitis in Animal Models and Its Mechanism

Methane Alleviates Lung Injury through the IL-10 Pathway by Increasing T Regulatory Cells in a Mouse Asthma Model